跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,787 条关于
“macular neovascularization”
全部
11,787
临床试验
10,578
药物
179
机构
44
资讯
986
去年
First Comprehensive Post-Marketing Safety Comparison Reveals Differing Adverse Event Profiles for Geographic Atrophy Treatments
去年
Samsung Bioepis' OfubizTM (Aflibercept) Biosimilar Approved in Europe for Ophthalmic Diseases
去年
Five-Year Study Shows Aflibercept Treat-and-Extend Regimen Maintains Vision in Neovascular AMD Patients
2年前
Biocon Biologics Secures UK Approval for Aflibercept Biosimilar YESAFILI, Expanding European Market Access
去年
Samsung Bioepis' Aflibercept Biosimilar, OfubizTM, Receives European Commission Approval
3个月前
OCT Biomarkers Distinguish Progression to Neovascular vs. Atrophic AMD in Intermediate Disease
去年
Alvotech Secures Japanese Approval for Three Biosimilars Including First Global Golimumab Biosimilar
去年
Massalia Therapeutics Launches with Seed Funding to Target Fibrosis-Neoplasm-Neovascularization Interface
去年
FDA-Approved Cimerli: First Interchangeable Biosimilar for Ocular Conditions Now Available
4个月前
Alteogen Receives Korean Approval for Aflibercept Biosimilar, Targeting Growing Retinal Disease Market
第 1 页，共 99 页
上一页
下一页
